The paper's citation list

No.
The paper's citation list
1
Therapeutic cancer vaccines revamping: technology advancements and pitfalls. 2021;32:1537 doi: 10.1016/j.annonc.2021.08.2153
2
Antitumor Properties of Epitope-Specific Engineered Vaccine in Murine Model of Melanoma. 2022;20:392 doi: 10.3390/md20060392
3
Lymph Node Delivery Strategy Enables the Activation of Cytotoxic T Lymphocytes and Natural Killer Cells to Augment Cancer Immunotherapy. 2021;13:22213 doi: 10.1021/acsami.1c03709
4
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy. 2021;14: doi: 10.1186/s13045-021-01080-8
5
In Silico Epitope Prediction Analyses Highlight the Potential for Distracting Antigen Immunodominance with Allogeneic Cancer Vaccines. 2021;1:115 doi: 10.1158/2767-9764.CRC-21-0029
6
Synthesis and antitumorigenesis effect of novel 2-amino -3-cyano pyridine derivatives containing sulfonamide moiety against breast cancer. 2024;1301:137309 doi: 10.1016/j.molstruc.2023.137309
Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/